In which industries is Centene primarily active?

Centene Corp is primarily active in the healthcare and managed care industries.

Who are the main competitors of Centene in the market?

The main competitors of Centene Corp in the market include UnitedHealth Group, Anthem Inc., Humana Inc., and CVS Health Corporation.

What is the history and background of the company Centene?

Centene Corp is a leading healthcare enterprise in the United States. Founded in 1984, the company has steadily grown to become a well-established player in the industry. Centene Corp focuses on providing comprehensive healthcare solutions to its members, ranging from Medicaid and Medicare programs to commercial insurance and individual insurance plans. With a strong commitment to improving access to high-quality healthcare, Centene Corp serves millions of individuals across the country. The company's history is marked by its dedication to innovation and collaboration, aiming to deliver cost-effective and patient-centered care. Centene Corp continues to evolve and expand its services, making it a prominent name in the healthcare sector.

What significant milestones has the company Centene achieved?

Centene Corp has achieved significant milestones over the years. One notable achievement is its inclusion in the Fortune 500 list, which showcases the company's success and prominence. Furthermore, Centene has expanded its presence through strategic acquisitions, enhancing its market position and diversifying its offerings. The company's commitment to innovation and delivering high-quality healthcare services has earned it recognition, such as being named one of the World's Most Admired Companies in the healthcare industry. Centene Corp continues to strive for excellence, constantly seeking ways to improve patient outcomes and reshape the healthcare landscape.

In which countries and regions is Centene primarily present?

Centene Corp is primarily present in the United States. As a leading healthcare enterprise, Centene operates across various states and serves millions of individuals through government-sponsored programs such as Medicaid and Medicare. With a comprehensive network of health plans and providers, Centene offers its services to diverse populations in areas including urban, rural, and underserved communities. By leveraging its expertise in managing healthcare benefits, Centene strives to improve access to quality care and enhance overall health outcomes for its members throughout the United States.

What values and corporate philosophy does Centene represent?

Centene Corp represents a commitment to providing high-quality healthcare services to individuals and communities in need. The company's corporate philosophy focuses on improving the health of its members by offering comprehensive, innovative, and cost-effective solutions. Centene prioritizes a patient-centric approach, ensuring access to affordable healthcare options and personalized care. With a strong emphasis on collaboration and integrity, Centene embraces diversity and inclusivity in its workforce and community partnerships. By delivering value-based care and promoting social responsibility, Centene Corp strives to improve health outcomes and enhance the overall well-being of its members and their communities.

What is the business model of Centene?

Centene Corp is a multinational company based in the USA that specializes in providing medical services for low-income individuals. The company has been operating since 1984 and is headquartered in St. Louis, Missouri. It employs over 70,000 employees and operates in 25 US states and the international market. Centene Corp has gained a good reputation in the market and is considered a leader in the industry.

What is the revenue of Centene 2026?

The expected revenue of Centene is 190.66 B USD. This figure is based on current financial data and reflects the company's business performance.

How high is the profit of Centene 2026?

The expected profit of Centene is 1.46 B USD. The net profit reflects the company's profitability after deducting all expenses.

What is the P/E ratio of Centene 2026?

The price-to-earnings ratio (P/E) of Centene is currently 21.77. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Centene stock.

What is the P/S ratio of Centene 2026?

The price-to-sales ratio (P/S) of Centene is currently 0.17. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Centene stock.

What is the Eulerpool Quality Score of Centene?

The Eulerpool Quality Score for Centene is 3/10.

What is the Centene ISIN?

The ISIN of Centene is US15135B1017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

What is the Centene WKN?

The WKN of Centene is 766458. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

What is the Centene ticker?

The ticker of Centene is CNC. The ticker symbol is used to trade Centene shares on the stock exchange.

How secure is the dividend of Centene?

Centene paid dividends every year for the past 0 years.

In which sector is Centene located?

Centene is assigned to the 'Health' sector.

In which currency does Centene pay out the dividend?

The dividends of Centene are distributed in USD.

Start Free Trial

Centene (CNC) Stock Price

Currency:

Centene Price

🇺🇸NYSE·CLOSED

64.60USD

Market closed

Today +/-

Today %

Centene (CNC) Stock | ISIN US15135B1017 | WKN 766458. The current Centene stock price is 64.6 USD (2026). Revenue is 190.66 B USD. Net income is 1.46 B USD. The P/E ratio is 21.77. Market capitalization is 31.86 B USD. Centene operates in the Health sector.

Centene stock price

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Centene over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Centene stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Centene's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Centene Stock Price History

Date	Centene Price

Access this data via the Eulerpool API

Docs Get Free API Key

Centene Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Revenue

EBIT

Net Income

Details

Centene Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 8:39 PM

REVENUE (M USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M USD)

NET INCOME (M USD)

NET INCOME GROWTH (%)

SHARES (M)

DOCUMENTS

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Centene generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Centene retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Centene's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Centene has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Centene's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Centene stock margins

The Centene margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Centene. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Centene.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

Centene Stock Revenue, EBIT, Earnings per Share

The Centene earnings per share therefore indicates how much revenue Centene has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Revenue per Share

EBIT per share

Earnings per Share

Details

Centene business model & stock analysis

The Centene Corporation is a leading provider of managed care and health insurance programs in the USA. The company is headquartered in St. Louis, Missouri and was founded in 1984. In recent years, it has experienced remarkable expansion and operates in many states across the USA. Business model: Centene operates a business model that focuses on managed care, meaning integrated healthcare systems where services from physicians, hospitals, and other healthcare facilities are bundled together. By bundling services, Centene can better control costs and improve the quality of healthcare. The company offers health insurance for both low-income individuals, such as Medicaid, as well as higher-income individuals. Different divisions: Centene Corp is divided into several divisions to be able to offer different types of insurance. One of the most important is Medicaid, the government health program for low-income individuals. Centene is the largest provider of Medicaid programs in the USA and has managed to establish a strong presence in many states. In addition to Medicaid, Centene also operates managed care programs for higher-income individuals, such as through partnerships with employers or through health insurance marketplaces. Products: In addition to basic health insurance products, Centene also offers specialized insurance programs tailored to the needs of individuals with specific health problems. This includes programs for individuals with diabetes, mental illnesses, or addictions. These programs offer better and specific treatment for these conditions, contributing to improved healthcare. Conclusion: Overall, Centene is one of the largest and fastest-growing companies in the US healthcare industry and plays an important role in providing health insurance in the USA. The company has developed a successful business model that focuses on managed care and offers a wide range of products to meet the diverse needs of customers. With a smart business strategy and a continuous focus on innovation and quality, Centene is a significant force in the healthcare sector in the United States of America.

Centene SWOT Analysis

Strengths

Centene Corp has several strengths that contribute to its success in the market. Firstly, the company has a strong financial position, with consistent revenue growth and profitability. This allows Centene to invest in expansion, innovation, and acquisitions, positioning itself as a market leader.

Secondly, Centene has a diversified product portfolio, offering a wide range of health insurance and managed care services. This diversification helps mitigate risks and allows the company to cater to various customer segments with different needs.

Lastly, Centene has established strong relationships with healthcare providers, enabling it to negotiate favorable contracts and ensure quality healthcare services for its customers. These partnerships enhance Centene's competitive advantage and help maintain strong customer satisfaction.

Weaknesses

Despite its strengths, Centene Corp also faces certain weaknesses that may hinder its growth. One weakness is its dependence on government-sponsored programs for a significant portion of its revenue. This exposes Centene to potential policy changes or budget constraints set by the government, impacting its financial performance.

Additionally, Centene's rapid growth and expansion have led to operational complexities and integration challenges. The company needs to effectively manage these complexities to ensure seamless operations and maintain service quality.

Opportunities

Centene Corp operates in a healthcare industry that experiences constant evolution and opportunities. One significant opportunity is the increasing demand for managed care and health insurance services, driven by the aging population and growing healthcare needs. Centene can further capitalize on this trend by expanding its market presence and offering innovative solutions.

Another opportunity lies in the advancement of technology and digitalization in the healthcare sector. Centene can leverage technology to improve operational efficiency, enhance customer experience, and develop telehealth and remote monitoring services. Embracing digital innovations would strengthen its competitive position in the market.

Threats

Centene Corp also faces several threats that could impact its business and market position. One critical threat is the regulatory and legislative changes in the healthcare industry. Changes in policies, reimbursement rates, or government contracts can significantly affect Centene's operations and financial performance.

Another threat stems from intense competition in the healthcare sector. Many players offer similar services, making it crucial for Centene to continuously differentiate itself and provide superior value to customers.

Additionally, the ongoing COVID-19 pandemic poses challenges to the healthcare industry, with potential disruptions in operations, increased claims, and changes in customer behavior. Centene needs to adapt to these uncertainties and effectively manage the associated risks.

Centene Segments

Centene Revenue by Segment (1/5)

3 Years
5 Years
10 Years
25 Years
Max

Details

Centene Revenue by Segment (2/5)

3 Years
5 Years
10 Years
25 Years
Max

Details

Centene Revenue by Segment (3/5)

3 Years
5 Years
10 Years
25 Years
Max

Details

Centene Revenue by Segment (4/5)

3 Years
5 Years
Max

Managed Care

Medicaid

Commercial

Medicare

Specialty Services

Other

Details

Centene Revenue by Segment (5/5)

3 Years
5 Years
Max

Managed Care

Medicare

Details

Centene Eulerpool Fair Value

Centene historical P/E ratio, EBIT multiple, and P/S ratio

Centene annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Centene shares outstanding

The number of shares was Centene in 2025 — This indicates how many shares 493.116 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

Price targets and forecasts for Centene are not yet available.

Centene Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
4/28/2026	2.17USD	48.06 BUSD	2026 Q1
2/6/2026	-1.24USD	48.87 BUSD	2025 Q4
4/23/2024	2.16USD	36.26 BUSD	2024 Q1
2/5/2024	0.42USD	36.58 BUSD	2023 Q4
7/24/2023	1.75USD	36.92 BUSD	2023 Q2
4/24/2023	2.14USD	37.5 BUSD	2023 Q1
2/6/2023	0.86USD	36.02 BUSD	2022 Q4
10/25/2022	1.25USD	36 BUSD	2022 Q3
7/26/2022	1.61USD	36.09 BUSD	2022 Q2
4/26/2022	1.7USD	35.01 BUSD	2022 Q1
2/8/2022	1USD	32.99 BUSD	2021 Q4
10/26/2021	1.26USD	32.09 BUSD	2021 Q3
7/27/2021	1.4USD	30.6 BUSD	2021 Q2
4/27/2021	1.61USD	29.94 BUSD	2021 Q1
2/9/2021	0.47USD	28.78 BUSD	2020 Q4
10/27/2020	0.98USD	28.65 BUSD	2020 Q3
7/28/2020	2.41USD	27.99 BUSD	2020 Q2
4/28/2020	1USD	24.66 BUSD	2020 Q1
2/4/2020	0.74USD	18.7 BUSD	2019 Q4
10/22/2019	0.96USD	18.73 BUSD	2019 Q3
7/23/2019	1.25USD	18.28 BUSD	2019 Q2
4/23/2019	1.35USD	17.73 BUSD	2019 Q1
2/5/2019	0.67USD	16.64 BUSD	2018 Q4
10/23/2018	0.89USD	16.26 BUSD	2018 Q3
7/24/2018	0.89USD	14.1 BUSD	2018 Q2
4/24/2018	0.97USD	13.39 BUSD	2018 Q1
2/6/2018	0.47USD	12.73 BUSD	2017 Q4
10/24/2017	0.63USD	11.96 BUSD	2017 Q3
7/25/2017	0.67USD	11.87 BUSD	2017 Q2
4/25/2017	0.53USD	11.59 BUSD	2017 Q1
2/7/2017	0.56USD	11.11 BUSD	2016 Q4
10/25/2016	0.58USD	11.13 BUSD	2016 Q3
7/26/2016	0.55USD	10.95 BUSD	2016 Q2
4/26/2016	0.37USD	7.39 BUSD	2016 Q1
2/9/2016	0.43USD	6.26 BUSD	2015 Q4
10/27/2015	0.39USD	5.87 BUSD	2015 Q3
7/28/2015	0.35USD	5.61 BUSD	2015 Q2
4/28/2015	0.24USD	5.19 BUSD	2015 Q1
2/3/2015	0.43USD	4.68 BUSD	2014 Q4
10/28/2014	0.24USD	4.29 BUSD	2014 Q3
7/22/2014	0.18USD	3.71 BUSD	2014 Q2
4/22/2014	0.11USD	3.3 BUSD	2014 Q1
2/4/2014	0.21USD	2.86 BUSD	2013 Q4
10/22/2013	0.21USD	2.72 BUSD	2013 Q3
7/23/2013	0.16USD	2.69 BUSD	2013 Q2
4/23/2013	0.1USD	2.5 BUSD	2013 Q1
2/5/2013	0.08USD	2.44 BUSD	2012 Q4
10/23/2012	0.12USD	2.26 BUSD	2012 Q3
7/24/2012	-0.03USD	2.02 BUSD	2012 Q2
4/24/2012	0.12USD	1.67 BUSD	2012 Q1
2/7/2012	0.14USD	1.46 BUSD	2011 Q4
10/25/2011	0.14USD	1.33 BUSD	2011 Q3
7/26/2011	0.14USD	1.32 BUSD	2011 Q2
4/26/2011	0.11USD	1.25 BUSD	2011 Q1
2/8/2011	0.12USD	1.15 BUSD	2010 Q4
10/26/2010	0.12USD	1.16 BUSD	2010 Q3
7/27/2010	0.11USD	1.12 BUSD	2010 Q2
4/27/2010	0.09USD	1.13 BUSD	2010 Q1
2/9/2010	0.13USD	1.12 BUSD	2009 Q4
10/27/2009	0.13USD	1.03 BUSD	2009 Q3
7/28/2009	0.11USD	960.9 MUSD	2009 Q2
4/28/2009	0.1USD	944.64 MUSD	2009 Q1
2/10/2009	0.13USD	941.49 MUSD	2008 Q4
10/28/2008	0.11USD	899.5 MUSD	2008 Q3
7/22/2008	0.1USD	860.02 MUSD	2008 Q2
4/22/2008	0.13USD	824.75 MUSD	2008 Q1
2/8/2008	0.12USD	788.36 MUSD	2007 Q4
10/23/2007	0.09USD	765.06 MUSD	2007 Q3
7/24/2007	0.07USD	726.32 MUSD	2007 Q2
4/24/2007	0.06USD	661.51 MUSD	2007 Q1
2/6/2007	0.1USD	700.27 MUSD	2006 Q4
10/24/2006	0.07USD	624.86 MUSD	2006 Q3
7/25/2006	0.03USD	504.27 MUSD	2006 Q2
4/25/2006	0.05USD	455.79 MUSD	2006 Q1
2/7/2006	0.08USD	425.55 MUSD	2005 Q4
10/25/2005	0.08USD	404.8 MUSD	2005 Q3
7/25/2005	0.08USD	353.7 MUSD	2005 Q2
4/25/2005	0.08USD	345.26 MUSD	2005 Q1
2/7/2005	0.07USD	284.66 MUSD	2004 Q4
10/25/2004	0.06USD	246.88 MUSD	2004 Q3
7/26/2004	0.06USD	235.18 MUSD	2004 Q2
4/26/2004	0.06USD	228.87 MUSD	2004 Q1
2/9/2004	0.06USD	209.43 MUSD	2003 Q4
10/27/2003	0.05USD	199.23 MUSD	2003 Q3

...

EESG©

Eulerpool ESG Scorecard© for the Centene stock

71/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions7,825

Scope 2 - Indirect emissions from purchased energy36,389

Scope 3 - Indirect emissions within the value chain1,184,419

Total CO₂ emissions44,214

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather—

Pesticides—

Palm Oil—

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees76

Percentage of women in management—

Percentage of Asian employees9

Share of Asian management7

Percentage of Hispanic/Latino employees16

Hispano/Latino Management share15

Percentage of Black employees23

Black Management Share18

Percentage of white employees47

White Management Share56

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Centene shareholder structure

%	Name	Stocks	Change	Date
11.79307%	The Vanguard Group, Inc.	58,153,529	+866,941	6/30/2025
5.41965%	BlackRock Institutional Trust Company, N.A.	26,725,179	-690,074	6/30/2025
5.36494%	Norges Bank Investment Management (NBIM)	26,455,361	+1,097,697	6/30/2025
4.70212%	State Street Investment Management (US)	23,186,927	+514,600	6/30/2025
4.17071%	Fidelity Management & Research Company LLC	20,566,461	+370,672	6/30/2025
4.14076%	Harris Associates L.P.	20,418,731	-717,208	6/30/2025
3.59605%	Capital World Investors	17,732,715	+2,822,774	6/30/2025
2.67861%	Geode Capital Management, L.L.C.	13,208,639	+279,637	6/30/2025
1.68291%	AQR Capital Management, LLC	8,298,682	-2,750,812	6/30/2025
1.63111%	Politan Capital Management, L.P.	8,043,255	-488,476	6/30/2025

...

Centene Executives and Management Board

Ms. Sarah London

(44)

Chief Executive Officer, Director · since 2021

Compensation20.6 MUSD

Compensation20.6 M USD

Mr. Andrew Asher

(56)

Chief Financial Officer, Executive Vice President

11.18 MUSD

Compensation11.18 M USD

Mr. Christopher Koster

(60)

Executive Vice President, General Counsel, Secretary

5.06 MUSD

Compensation5.06 M USD

Ms. Susan Smith

(49)

Chief Operating Officer

3.52 MUSD

Compensation3.52 M USD

Mr. Frederick Eppinger

(66)

Non-Executive Independent Chairman of the Board

590,026USD

Compensation590,026 USD

Frequently asked questions about Centene

The business model of Centene Corp is focused on providing healthcare services to individuals and families through government-sponsored programs. It operates as a managed care organization, offering health plans to Medicaid, Medicare, and the Health Insurance Marketplace recipients. Centene Corp aims to reduce healthcare costs, improve health outcomes, and increase access to quality care for its members. Through its network of healthcare providers and innovative programs, the company strives to deliver comprehensive and cost-effective healthcare solutions. Centene Corp actively collaborates with government agencies and community organizations to address the healthcare needs of underserved populations.

Fair Value PRO

62.02 USD

Over-/Undervaluation PRO

13.0% undervalued

Sector

Health

Industry

Health Care Providers & Services

Number of shares

493,116,000

Employees

56,600

Revenue per Employee

3.44 M USD

Revenue growth Ø5 years

9.11 %

EBIT growth Ø5 years

—

Net Income growth Ø5 years

—

Website centene.com

Country

United States 🇺🇸

Currency

USD

Initial public offering

Dec 13, 2001

ISIN

US15135B1017

Cusip

15135B101

Sedol

2807061

Market capitalization

19.95 B USDLarge Cap

Centene Directors Dealings

Quality Investing

3 / 10

Revenue growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

-0.19

P/E ratio

-4.77

P/Ee 2026

21.77

P/Ee 2027

15.66

P/Ee 2028

9.67

P/Ee 2029

7.76

P/Ee 2030

6.87

P/S

0.16

P/Se

0.17

EV/EBIT

—

P/B Ratio

ROE (Return on Equity)

-33.45 %

ROA (Return on Assets)

-8.7 %

ROCE (Return on Capital Employed)

-1.56 %

ROIC (Return on Invested Capital)

-17.87 %

Gross Margin

7.12 %

EBIT Margin

-0.16 %

Net Margin

-3.43 %

EPS (Earnings Per Share)

-13.53 USD

Net Debt / EBIT

1.56

Debt/Equity

0.87

Last updated Jun 10, 2026, 8:39 PM

Centene Peer Group

Progyny Inc

Healthequity Inc

Molina Healthcare Inc

Humana Inc

UnitedHealth Group Inc

Centene Ticker

DÜSSELDORF · QEN.DUFRANKFURT · QEN.FLONDON · 0HVB.LLONDON STOCK EXCHANGE · 0HVB.LMILAN · 1CNC.MIMUNICH · QEN.MUNEW YORK · CNCSIX · QEN.SW

Centene FIGI

CNC:US · BBG000BDXCJ5CNC:UA · BBG000BDXD21CNC:UC · BBG000BDXDX7CNC:UN · BBG000BDXFR9CNC:UP · BBG000BDXG51CNC:UB · BBG000BDXJG3CNC:UT · BBG000BDXJT9CNC:UM · BBG000BDXKD3CNC:UX · BBG000BDXKT6CNC:UD · BBG000BDXP06CNC:UF · BBG000BDXQM0CNC:VY · BBG000BDXR84

All fundamentals and in-depth analysis of Centene

Our stock analysis for Centene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Centene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Centene Directors Dealings→

Centene Stocks→

Centene Market capitalization→

Centene Debt→

Centene Liabilities→

Centene Equity→